Variable | RCC (n = 89) | Controls (n = 38) |
---|---|---|
Age Median (range) | 62 (25-85) | 57 (23-89) |
Sex - no. (%) | ||
Male | 52 (58.4) | 20 (52.6) |
Female | 37 (41.6) | 18 (47.4) |
Race - no. (%) | ||
Caucasian | 66 (74.2) | 28 (70.0) |
African American | 9 (10.1) | 6 (15.0) |
Hispanic | 9 (10.1) | 6 (15.0) |
East Indian | 4 (4.5) | 0 |
Asian | 1 (1.1) | 0 |
Diagnosis - no. (%) | ||
RCC | 89 (100) | |
Stones | 27 (71.1) | |
Hematuria | 9 (23.7) | |
Renal Cyst | 2 (5.3) | |
Approach - no. (%) | ||
Ablation | 6 (6.7) | |
Nephrectomy | 83 (93.3) | |
Open | 42 (50.6) | |
Laparoscopic | 41 (49.4) | |
Radical | 36 (43.4) | |
Partial | 47 (56.6) | |
AJCC Stage† - no. (%) | ||
I | 60 (73.2) | |
II | 7 (8.5) | |
III | 15 (18.3) | |
IV | 0 | |
pT Classification† - no. (%) | ||
T1a | 41 (49.4) | |
T1b | 20 (24.1) | |
T2 | 7 (8.4) | |
T3 | 1 (1.2) | |
T3a | 5 (6.0) | |
T3b | 9 (10.8) | |
T3c | 0 | |
T4 | 0 | |
Pathologic Size† - median (range) | 4.1 (1.3-25) | |
LN Involvement† - no. (%) | ||
NX | 71 (85.5) | |
N0 | 11 (13.3) | |
N1 | 1 (1.2) | |
Histology - no. (%) | ||
Clear Cell | 69 (77.5) | |
Papillary | 14 (15.7) | |
Chromophobe | 5 (5.6) | |
Unclassified RCC | 1 (1.1) | |
Fuhrman Grade† - no. (%) | ||
1 | 10 (12.0) | |
2 | 44 (53.01) | |
3 | 26 (31.33) | |
4 | 3 (3.6) |